These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35640922)

  • 1. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA.
    Monahan KH; Bunch TJ; Mark DB; Poole JE; Bahnson TD; Al-Khalidi HR; Silverstein AP; Daniels MR; Lee KL; Packer DL;
    Europace; 2022 Oct; 24(9):1430-1440. PubMed ID: 35640922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
    Poole JE; Bahnson TD; Monahan KH; Johnson G; Rostami H; Silverstein AP; Al-Khalidi HR; Rosenberg Y; Mark DB; Lee KL; Packer DL;
    J Am Coll Cardiol; 2020 Jun; 75(25):3105-3118. PubMed ID: 32586583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.
    Packer DL; Piccini JP; Monahan KH; Al-Khalidi HR; Silverstein AP; Noseworthy PA; Poole JE; Bahnson TD; Lee KL; Mark DB;
    Circulation; 2021 Apr; 143(14):1377-1390. PubMed ID: 33554614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Mark DB; Anstrom KJ; Sheng S; Piccini JP; Baloch KN; Monahan KH; Daniels MR; Bahnson TD; Poole JE; Rosenberg Y; Lee KL; Packer DL;
    JAMA; 2019 Apr; 321(13):1275-1285. PubMed ID: 30874716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
    JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial.
    Bahnson TD; Giczewska A; Mark DB; Russo AM; Monahan KH; Al-Khalidi HR; Silverstein AP; Poole JE; Lee KL; Packer DL;
    Circulation; 2022 Mar; 145(11):796-804. PubMed ID: 34933570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.
    Zeitler EP; Li Y; Silverstein AP; Russo AM; Poole JE; Daniels MR; Al-Khalidi HR; Lee KL; Bahnson TD; Anstrom KJ; Packer DL; Mark DB;
    J Am Heart Assoc; 2023 Feb; 12(3):e027871. PubMed ID: 36688367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trial.
    Cappato R; Mark DB; Silverstein AP; Noseworthy PA; Bonitta G; Poole JE; Piccini JP; Bahnson TD; Daniels MR; Al-Khalidi HR; Lee KL; Packer DL;
    Am Heart J; 2024 Apr; 270():103-116. PubMed ID: 38307365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA Trial.
    Russo AM; Zeitler EP; Giczewska A; Silverstein AP; Al-Khalidi HR; Cha YM; Monahan KH; Bahnson TD; Mark DB; Packer DL; Poole JE;
    Circulation; 2021 Feb; 143(7):661-672. PubMed ID: 33499668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in quality of life after catheter ablation for paroxysmal versus long-standing persistent atrial fibrillation: a prospective study with 3-year follow-up.
    Bulková V; Fiala M; Havránek S; Simek J; Skňouřil L; Januška J; Spinar J; Wichterle D
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial.
    Kistler PM; Chieng D; Sugumar H; Ling LH; Segan L; Azzopardi S; Al-Kaisey A; Parameswaran R; Anderson RD; Hawson J; Prabhu S; Voskoboinik A; Wong G; Morton JB; Pathik B; McLellan AJ; Lee G; Wong M; Finch S; Pathak RK; Raja DC; Sterns L; Ginks M; Reid CM; Sanders P; Kalman JM
    JAMA; 2023 Jan; 329(2):127-135. PubMed ID: 36625809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and long-term catheter ablation outcome in long-standing persistent atrial fibrillation patients with non-pulmonary vein triggers.
    Hung Y; Lo LW; Lin YJ; Chang SL; Hu YF; Chung FP; Tuan TC; Chao TF; Liao JN; Walia R; Te ALD; Yamada S; Lin CH; Chang YT; Lin CY; Chan CS; Liao YC; Raharjo S; Allamsetty S; Chen SA
    Int J Cardiol; 2017 Aug; 241():205-211. PubMed ID: 28456483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.
    Boersma L; Koźluk E; Maglia G; de Sousa J; Grebe O; Eckardt L; Hokanson RB; Hemingway LA; Ostern E; Park HS; Rovaris G; Arribas F; Scharf C; Csanádi Z; Arenal Á; Laurenzi F; Klaver M; Goette A
    Europace; 2020 Jun; 22(6):888-896. PubMed ID: 32219388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Implications and Efficacy of Catheter Ablation by Atrial Fibrillation Type.
    Miyama H; Takatsuki S; Ikemura N; Kimura T; Katsumata Y; Yamashita S; Yamaoka K; Ibe S; Seki Y; Yamashita T; Hashimoto K; Ueda I; Ueno K; Ohki T; Fukuda K; Kohsaka S
    J Am Heart Assoc; 2023 Sep; 12(18):e029321. PubMed ID: 37681532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation for persistent atrial fibrillation: patterns of recurrence and impact on quality of life and health care utilization.
    Crowley R; Chieng D; Sugumar H; Ling LH; Segan L; William J; Prabhu S; Voskoboinik A; Wong G; Morton JB; Lee G; McLellan AJ; Wong M; Pathak RK; Sterns L; Ginks M; Sanders P; Kalman JM; Kistler PM
    Eur Heart J; 2024 Aug; 45(29):2604-2616. PubMed ID: 38759110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA Trial.
    Bunch TJ; Poole JE; Silverstein AP; Lee KL; Al-Khalidi HR; Hindricks G; Romanov A; Pokushalov E; Bahnson TD; Daniels MR; Piccini JP; Mark DB; Packer DL;
    Circ Arrhythm Electrophysiol; 2024 May; 17(5):e012697. PubMed ID: 38629286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Chew DS; Li Y; Cowper PA; Anstrom KJ; Piccini JP; Poole JE; Daniels MR; Monahan KH; Davidson-Ray L; Bahnson TD; Al-Khalidi HR; Lee KL; Packer DL; Mark DB;
    Circulation; 2022 Aug; 146(7):535-547. PubMed ID: 35726631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.
    Thomas KL; Al-Khalidi HR; Silverstein AP; Monahan KH; Bahnson TD; Poole JE; Mark DB; Packer DL;
    J Am Coll Cardiol; 2021 Jul; 78(2):126-138. PubMed ID: 34238436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Effect of Continued Antiarrhythmic Drug Treatment on Top of Optimized Pulmonary Vein Isolation in Patients With Persistent Atrial Fibrillation: Results From the POWDER-AF2 Trial.
    Demolder A; O'Neill L; El Haddad M; Scherr D; Vijgen J; Wolf M; Berte B; Bisbal F; Johannessen A; Rivero-Ayerza M; De Potter T; De Becker B; Polain de Waroux JL; Knecht S; Tavernier R; Duytschaever M
    Circ Arrhythm Electrophysiol; 2023 Nov; 16(11):e012043. PubMed ID: 37921006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation vs. antiarrhythmic drugs as 'first-line' initial therapy for atrial fibrillation: a pooled analysis of randomized data.
    Chen S; Pürerfellner H; Ouyang F; Kiuchi MG; Meyer C; Martinek M; Futyma P; Zhu L; Schratter A; Wang J; Acou WJ; Ling Z; Yin Y; Liu S; Sommer P; Schmidt B; Chun JKR
    Europace; 2021 Dec; 23(12):1950-1960. PubMed ID: 34405878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.